USSTOCK.TODAY
Market Closed
Log in Sign up

Alvotech expects product sales recovery and record Q4 results

The Motley Fool +1 · ·by G4L

ALVO
ALVO Alvotech
$4.19 -10.28%
View chart & analysis →
  1. 1Alvotech recorded $58 million in product and service revenue in Q3, indicating a sequential recovery.
  2. 2Alvotech recorded an EBITDA of $78 million for the first nine months of 2026, achieving a 15% year-over-year increase.
  3. 3Management expects the fourth quarter to be the strongest quarter in the company's history.

So what's the key point?

Alvotech's product sales are recovering, reaching $58 million. Management expects the final quarter of this year to deliver the best results in the company's history.

Source The Motley Fool +1 · View original ↗

Related 3-line summaries

US FDA Approves Alvotech's New Manufacturing Process for Simlandi Investing.com · Oct 20Alvotech SA shares jump 13.5% on US FDA supplemental approval for AVT02 manufacturing facility Investing.com +1 · Oct 6CAE Announces Q2 Results and Raises FY2027 Guidance The Motley Fool +1 · yesterday
Today's 5 AI picks, all free
Nothing hidden: past picks and how they did against the S&P 500.
See today's picks →
← Back to news